the presence of skin microbiota. Denatured decorin and biglycan caused lower TLR4 activity than controls, possibly due to endotoxin in the recombinant reagents.
CONCLUSION:
The results indicate that there may be endogenous molecules released from the burned tissue and cells that are able to stimulate the TLR4 pathway. Stimulation of the TLR4 pathway would lead to production of Type 1 interferons and proinflammatory cytokines, such as IL-1β, IL-6, TNF-α, which may promote fibrosis and HTS formation. We will further explore the mechanism by culturing burn tissues and SLRPs with deep dermal fibroblasts. These studies will help in the development of future therapeutics, providing benefits to patients suffering with HTS and other fibroproliferative disorders. Massachusetts General Hospital, Boston, MA, USA PURPOSE: Articular cartilage lesions in large joints have been successfully treated with autologous chondrocyte implantation (ACI) with or without a matrix scaffold (e.g., MACI). However, lesions in small joints of the hand and wrist cannot be easily treated with current ACI techniques. Fractional treatment, either mechanically or by laser, to make perforations into skin has been shown promote regeneration. The purpose of this study was to develop a new strategy that combines fractional treatment with our method for generating new cartilage matrix using dynamic Self-Regenerating Cartilage (dSRC) to treat cartilage lesions in the joints of the hand and wrist.
METHODS: 10e7 freshly harvested autologous swine chondrocytes were cultured on a rocker for 14 days at 37 degree C to form dSRC. The dSRC was then mixed with collagen gel and placed into mechanically punched holes or laser (wavelength 10.6 µm) drilled holes at the center of a swine articular cartilage disc and capped with collagen gel. The control group consisted of isolated chondrocytes (3x10e7 cells per mL) injected into punched or laser drilled holes. Four groups were tested -(1) dSRC + 0.3 mm laser hole, (2) dSRC + 0.3 mm punch hole, (3) chondrocytes + 0.3 mm laser hole, and (4) chondrocytes + 0.3 mm punch hole. The cartilage discs were cultured in medium at 37 degree C for 8 weeks (n=6/group) then evaluated. In a pilot, in vivo study, the dSRC were encapsulated in collagen hydrogels and placed into 0.3 mm diameter punched and laser drilled holes in swine articular cartilage discs and capped with hydrogel. These discs were implanted subcutaneously in female nude mice. Constructs were harvested at 8 weeks. All constructs were evaluated histologically and immunohistochemically for cartilage formation and integration with native cartilage.
RESULTS:
After 8 weeks in vitro, dSRC-treated constructs generated contiguous new cartilage matrix, compared to isolated chondrocyte-filled constructs that showed only pericellular matrix formation. dSRC groups demonstrated intense staining with Safranin-O and Toluidine blue stains indicating high glycosaminoglycan (GAG) production when compared to faint staining of groups treated with isolated chondrocytes. After 8 weeks in vivo in mice, contiguous cartilage matrix was observed in both dSRC filled punched holes and CO 2 laser-drilled holes. Immunohistochemical staining further confirmed that the matrix of dSRC group was typical of normal hyaline cartilage, rich in collagen type II and no collagen type I, similar to native cartilage. Results of this study demonstrate that dSRC capped with hydrogels can successfully engineer contiguous articular cartilage matrix in both mechanical and fractional laser created environments.
CONCLUSIONS:
Fractional treatment combined with dSRC demonstrates successful hyaline cartilage formation and integration with native cartilage both in vitro and in vivo. Such a strategy could be employed to translate ACI techniques commonly used in the knee to treat cartilage defects or osteoarthritis in the smaller joints of the hand and wrist. 
PURPOSE:
Vascularized composite allotransplantation (VCA) can include vascularized bone marrow (VBM) to potentially generate chimerism and subsequent tolerance in the recipient. While increasing ischemia time is known to be detrimental to free flaps and solid organ transplants, it is unknown whether increasing VCA ischemia time may diminish VBM's capacity to achieve chimerism and tolerance. This study determines whether increasing cold ischemia time results in decreased peripheral chimerism levels, increasing loss of the donor bone marrow compartment, and increased skin paddle rejection in a murine VCA model.
METHODS:
Twenty-three adult Lewis rats received osteomyocutaneous hind limb allografts from 3 groups of Brown-Norway rats. The groups underwent 0, 6, and 12 hours of cold ischemia at 4°C (n=8, 6, and 9 respectively). Immunosuppressive conditioning consisted of anti-lymphocyte serum 1cc 3 days pre-operatively and on post-op day (POD) 1, tacrolimus 2mg/kg/day for PODs 1-7, and then concluded with rapamycin 3mg/kg/day for PODs 8-28. Peripheral chimerism levels were drawn after POD 30. Skin paddle was observed for 30 days after immunosuppression cessation for rejection or tolerance. Allograft was collected at POD 60 for flow cytometry and histologic analysis.
RESULTS:
Peripheral chimerism levels in both myeloid and lymphoid lines were decreased in the 12 & 6 hours groups versus 0 hours (p<0.01). At POD 60, the amount of donor cells in the allograft bone marrow was significantly decreased at 12 & 6 hours versus the 0 hours group (p<0.05). At 12 hours, hematoxylin & eosin histology demonstrated significantly increased reactive lymphocytes, increased stroma, significantly decreased hematopoetic cells, and significant myelofibrosis. At 6 hours, moderate stromal increases, moderately decreased hematopoetic cells, and moderate myelofibrosis was observed. Trichrome staining revealed viable bone at all time points though with there were increasing amounts of collagen deposition with increasing ischemia and osteoslerosis was noted at 12 hours. Microvasculature was preserved at all time points. By POD 60, 0% of skin paddles survived in the 12 hours group, 17% at 6 hours, and 73% at 0 hours.
CONCLUSION:
With increasing ischemia time prior to VCA re-vascularization, there is decreased peripheral chimerism levels, increased loss of donor hematopoetic cells in the donor bone marrow, and increased skin paddle rejection. These findings indicate that ischemia time may significantly limit the capacity for VBM to facilitate chimerism and subsequent VCA tolerance and thus strategies using VBM to induce tolerance may need to consider the additional obstacle of time. Prolonged ischemia time may be a contributing factor to the absence of stable chimerism and tolerance in human VBM-bearing VCA recipients. 
